Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Combined 5-aminolevulinic acid and ferric ammonium citrate treatment promotes hair follicle growth by activating dermal papilla cells.

Ryu HW., Oh ES., Kim S.

Laboratory Study on Hair Loss, published in FEBS Open Bio (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
FEBS Open Bio (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
41873782
DOI
10.1002/2211-5463.70230

Abstract (original English)

Although 5-aminolevulinic acid (5-ALA) has shown potential for hair growth in previous studies, the molecular mechanisms remain unclear. In this study, we investigated the combined effect of 5-ALA with ferric ammonium citrate (FAC) in human hair follicle models. At low micromolar concentrations, 5-ALA/FAC treatment increased proliferation of dermal papilla cells, keratinocytes, fibroblasts, and adipose-derived stem cells, and rapidly activated ERK and AKT signaling. This treatment also upregulated hair-inductive genes and restored their suppression by dihydrotestosterone or oxidative stress. In functional assays, 5-ALA/FAC treatment induced hair follicle-like structures in reconstituted skin and enhanced hair shaft elongation in ex vivo organ culture. These findings indicate that 5-ALA/FAC treatment stimulates human hair follicle growth and support its potential as a therapeutic candidate for hair loss.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansHair FollicleCell ProliferationFerric CompoundsAminolevulinic AcidKeratinocytesDermisFibroblastsSignal TransductionCells, Cultured

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research